Celestial Biolabs Limited - Due diligence report

A 360° intelligence report on Celestial Biolabs: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1997-11-19 Hyderabad, Telangana Active Listed Active Compliant
Share
Connect MCP
CB Celestial Biolabs Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Celestial Biolabs — 360° Intelligence Report

Generated from MCA filings & public records
44/100
Trust Score
Caution Indicated

Celestial Biolabs is assessed as Caution Indicated with a Trust Score of 44/100. Celestial Biolabs is an active public limited indian non-government company incorporated in 1997, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Aug 2026 from the latest processed filings. Celestial Biolabs Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
44/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
21/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).

Charges position: 2 open (21.10 cr) · 4 satisfied (8.90 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India3 48.0 cr
3I Infotech Trusteeship Services Limited1 48.0 cr
Technology Development Board1 48.0 cr
Model Financial Corporation Ltd.1 48.0 cr
Compliance Score: 21/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • Flagged by authority: NSE, MSEI, SEBI.
  • Litigation present in 2 court forum(s).
  • 3 auditor resignation(s) filed - latest: B V SWAMI & CO. on 2019-09-30.
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
AMIT KUMAR SINGH 01234567 Director 01/04/2018 6 yrs Approved
GANGADHARUNI DURGA NARASIMHA KUMAR 01234567 Director 01/04/2018 6 yrs Approved
SADA NAGA LATHA 01234567 Director 01/04/2018 6 yrs Approved
RAKLE MATHUR NATH 01234567 Director 01/04/2018 6 yrs Approved
ARVIND DEVIPRASAD SHARMA 01234567 Director 01/04/2018 6 yrs Approved
PRABHAKAR KORADA 01234567 Director 01/04/2018 6 yrs Approved
PADMA SINGH 01234567 Director 01/04/2018 6 yrs Approved
Naga Latha Sada 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • GANGADHARUNI DURGA NARASIMHA KUMAR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
13 allotment(s) · 3 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: AMIT KUMAR SINGH (Managing Director) · ARVIND DEVIPRASAD SHARMA (CFO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 65
Growth signals & trust indicators
Operating for 28+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (21/100).
2 open charge(s) registered - assets are encumbered.
3 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment22/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 21.10 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view36/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
23 May 2024
Last AGM held
Annual general meeting
22 Apr 2024
Director ceased
PADMANABHA RAO AMARACHINTA
31 Mar 2023
Latest balance sheet
Filed with ROC
02 Sep 2022
Director appointed
GANGADHARUNI DURGA NARASIMHA KUMAR (Director)
Director appointed
RAKLE MATHUR NATH (Director)
Director appointed
ARVIND DEVIPRASAD SHARMA (CFO)
Director appointed
PRABHAKAR KORADA (Director)
16 May 2022
Director appointed
SADA NAGA LATHA (Company Secretary)
Director appointed
Naga Latha Sada (Company Secretary)
21 Jul 2020
Director ceased
ADITYA NARAYAN SINGH
03 Sep 2018
Director ceased
JEETAINDER ROY GOUR
28 Sep 2017
Director appointed
AMIT KUMAR SINGH (Managing Director)
31 Mar 2017
Share transfer (FY 2017)
20000.00000000 shares to BEGUM
30 Nov 2016
Securities allotted
2100000 Equity Shares - 5.45 cr raised
31 Mar 2016
Share transfer (FY 2016)
5000.00000000 shares to SASTRI
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
8 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 13 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
R.K. Sales Private Limited U00062BR1994PTC006185 Patna-4, Bihar, India
Perilla Life Science Private Limited U33309MP2021PTC070809 Indore, Madhya Pradesh, India
Ats Engineers Private Limited U25209HR1996PTC033278 Faridabad, Haryana, India
Saiprasad Chemical Specialities Private Limited U24100MH2004PTC146898 Dombivli, Maharashtra, India
Orcked Healthcare Private Limited U24239UP2020PTC125858 Allahabad, Uttar Pradesh, India
Be Pellets Limited U24232CH2016PLC035921 Chandigarh, Chandigarh, India
Merelin Life Sciences Private Limited U85191DL2010PTC199534 New Delhi, Delhi, India
Herbalray Private Limited U21001DL2010PTC210804 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Celestial Biolabs before audits and certifications: compliance score 21/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Celestial Biolabs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Celestial Biolabs - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 44/100, distress signals and MSME payment-delay disclosures - know whether Celestial Biolabs pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Celestial Biolabs - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Celestial Biolabs an active company?

Celestial Biolabs has MCA status “Active” with a compliance score of 21/100 (Caution Indicated).

Is Celestial Biolabs financially healthy?

Celestial Biolabs has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Celestial Biolabs?

Its overall Trust Score is 44/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Celestial Biolabs?

Promoters hold the largest single block of equity - exact percentages are in the full report. 8 active director(s) are on record.

Does Celestial Biolabs have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Celestial Biolabs up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 21/100 (Caution Indicated).

Is it risky to lend to Celestial Biolabs?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.